AAAAAA

   
Results: 1-7 |
Results: 7
HIGH DIURETIC DOSES ARE ASSOCIATED WITH SUDDEN-DEATH IN PATIENTS WITHADVANCED HEART-FAILURE - THE PRAISE TRIAL
Authors: NEUBERG GW OCONNOR CM MILLER AB BELKIN RN CARSON PE CROPP AB FRID D NYE R PRESSLER ML WERTHEIMER JH PACKER M
Citation: Gw. Neuberg et al., HIGH DIURETIC DOSES ARE ASSOCIATED WITH SUDDEN-DEATH IN PATIENTS WITHADVANCED HEART-FAILURE - THE PRAISE TRIAL, Circulation, 98(17), 1998, pp. 1568-1568
EFFECT OF AMLODIPINE ON MODE OF DEATH AMONG PATIENTS WITH ADVANCED HEART-FAILURE IN THE PRAISE TRIAL
Authors: OCONNOR CM CARSON PE MILLER AB PRESSLER ML BELKIN RN NEUBERG GW FRID DJ CROPP AB ANDERSON S WERTHEIMER JH DEMETS DL
Citation: Cm. Oconnor et al., EFFECT OF AMLODIPINE ON MODE OF DEATH AMONG PATIENTS WITH ADVANCED HEART-FAILURE IN THE PRAISE TRIAL, The American journal of cardiology, 82(7), 1998, pp. 881-887
EFFECT OF AMLODIPINE ON MORBIDITY AND MORTALITY IN SEVERE CHRONIC HEART-FAILURE
Authors: PACKER M OCONNOR CM GHALI JK PRESSLER ML CARSON PE BELKIN RN MILLER AB NEUBERG GW FRID D WERTHEIMER JH CROPP AB DEMETS DL
Citation: M. Packer et al., EFFECT OF AMLODIPINE ON MORBIDITY AND MORTALITY IN SEVERE CHRONIC HEART-FAILURE, The New England journal of medicine, 335(15), 1996, pp. 1107-1114
EFFECT OF AMLODIPINE ON MODE OF DEATH IN SEVERE CHRONIC HEART-FAILURE- THE PRAISE TRIAL
Authors: OCONNOR CM BELKIN RN CARSON PE CROPP AB FRID DJ MILLER AB NEUBERG GW PRESSLER ML WERTHEIMER JH PACKER M
Citation: Cm. Oconnor et al., EFFECT OF AMLODIPINE ON MODE OF DEATH IN SEVERE CHRONIC HEART-FAILURE- THE PRAISE TRIAL, Circulation, 92(8), 1995, pp. 676-676
DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE LONG-TERM EFFICACY OF CARVEDILOL IN PATIENTS WITH SEVERE CHRONIC HEART-FAILURE
Authors: KRUM H SACKNERBERNSTEIN JD GOLDSMITH RL KUKIN ML SCHWARTZ B PENN J MEDINA N YUSHAK M HORN E KATZ SD LEVIN HR NEUBERG GW DELONG G PACKER M
Citation: H. Krum et al., DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE LONG-TERM EFFICACY OF CARVEDILOL IN PATIENTS WITH SEVERE CHRONIC HEART-FAILURE, Circulation, 92(6), 1995, pp. 1499-1506
LYMPHOCYTE G-PROTEINS REFLECT RESPONSE TO TREATMENT IN CONGESTIVE-HEART-FAILURE
Authors: HORN EM KUKIN ML NEUBERG GW GOLDSMITH RL MCCARTY M GRATCH M MEDINA N YUSHAK M PACKER M BILEZIKIAN JP
Citation: Em. Horn et al., LYMPHOCYTE G-PROTEINS REFLECT RESPONSE TO TREATMENT IN CONGESTIVE-HEART-FAILURE, The American heart journal, 129(1), 1995, pp. 98-106
CAN FURTHER BENEFIT BE ACHIEVED BY ADDING FLOSEQUINAN TO PATIENTS WITH CONGESTIVE-HEART-FAILURE WHO REMAIN SYMPTOMATIC ON DIURETIC, DIGOXIN, AND AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR - RESULTS OF THE FLOSEQUINAN-ACE INHIBITOR TRIAL (FACET)
Authors: MASSIE BM BERK MR BROZENA SC ELKAYAM U PLEHN JF KUKIN ML PACKER M MURPHY BE NEUBERG GW STEINGART RM LEVINE TB DEHAAN H
Citation: Bm. Massie et al., CAN FURTHER BENEFIT BE ACHIEVED BY ADDING FLOSEQUINAN TO PATIENTS WITH CONGESTIVE-HEART-FAILURE WHO REMAIN SYMPTOMATIC ON DIURETIC, DIGOXIN, AND AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR - RESULTS OF THE FLOSEQUINAN-ACE INHIBITOR TRIAL (FACET), Circulation, 88(2), 1993, pp. 492-501
Risultati: 1-7 |